HCA Healthcare Target Price

See HCA Healthcare's analyst price targets ($450) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$426.94

Average Target Price

$445.00

4.2% upside

18 analysts in the last 4 months

High: $579 | Low: $369

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-07-28	Goldman Sachs	$485	13.6% upside
2026-07-27	Robert W. Baird	$393	7.9% downside
2026-07-27	Deutsche Bank	$476	11.5% upside
2026-07-27	Morgan Stanley	$380	11% downside
2026-07-27	OppenheimerMichael Wiederhorn	$485	13.6% upside
2026-07-27	Barclays	$387	9.4% downside
2026-07-27	UBS	$579	35.6% upside
2026-07-27	KeyBanc	$435	1.9% upside
2026-07-20	Wells FargoStephen Baxter	$369	13.6% downside
2026-07-16	Barclays	$402	5.8% downside
2026-07-15	RBC Capital	$435	1.9% upside
2026-07-14	Jefferies	$450	5.4% upside
2026-07-13	Wells Fargo	$428	0.2% upside
2026-07-08	Barclays	$427	0% upside
2026-07-07	Cantor Fitzgerald	$525	23% upside
2026-07-07	Raymond JamesSarah James	$528	23.7% upside
2026-06-04	Truist Financial	$413	3.3% downside
2026-06-04	Bernstein	$413	3.3% downside
2026-04-27	KeyBanc	$510	19.5% upside
2026-04-27	Stephens	$530	24.1% upside
2026-04-27	Barclays	$496	16.2% upside
2026-04-27	Wells Fargo	$436	2.1% upside
2026-04-27	RBC Capital	$534	25.1% upside
2026-04-27	Oppenheimer	$520	21.8% upside
2026-04-27	Truist Financial	$535	25.3% upside
2026-04-24	Jefferies	$525	23% upside
2026-02-23	UBS	$635	48.7% upside
2026-02-09	Bernstein	$541	26.7% upside
2026-02-02	Mizuho Securities	$540	26.5% upside
2026-01-30	Wells Fargo	$481	12.7% upside
2026-01-28	UBS	$598	40.1% upside
2026-01-28	BarclaysAndrew Mok	$551	29.1% upside
2026-01-28	KeyBanc	$503	17.8% upside
2026-01-28	UBS	$588	37.7% upside
2026-01-28	Oppenheimer	$540	26.5% upside
2026-01-28	RBC Capital	$555	30% upside
2026-01-28	KeyBanc	$550	28.8% upside
2026-01-22	KeyBanc	$500	17.1% upside
2026-01-07	Wells FargoStephen Baxter	$452	5.9% upside
2026-01-06	Bernstein	$503	17.8% upside
2025-12-18	Mizuho Securities	$520	21.8% upside
2025-10-27	Oppenheimer	$500	17.1% upside
2025-10-27	Raymond JamesSarah James	$525	23% upside
2025-10-27	Goldman SachsScott Fidel	$520	21.8% upside
2025-10-27	Morgan Stanley	$425	0.5% downside
2025-10-27	UBS	$525	23% upside
2025-10-27	Barclays	$494	15.7% upside
2025-10-27	RBC CapitalBen Hendrix	$482	12.9% upside
2025-10-27	StephensRaj Kumar	$500	17.1% upside
2025-10-27	Truist Financial	$495	15.9% upside

HCA Healthcare (HCA) FAQ

HCA Healthcare posts a target price of $450. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

A target price of $450 for HCA means covering analysts, on average, see the stock 4.2% upside of $426.94 over about 12 months. Dig into who set the high and low targets and how recently they updated — freshness matters as much as the average itself.

Context for HCA's target price usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; HCA Healthcare's other metric pages and overview cover the third.

Judging HCA Healthcare against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in target price easier to interpret. Start with $450 here, then scan peer and history charts to see if the gap is persistent.